PRESS RELEASE published on 11/20/2024 at 18:48, 1 year 5 months ago Acquisition ou cession des actions de l'émetteur / Information relative au contrat de liquidité Fin du contrat de liquidité entre Mauna Kea Technologies et Gilbert Dupont avec transfert des titres et espèces. Détails des moyens au 20 novembre 2024 et précédemment. Informations sur Mauna Kea Technologies Dispositifs Médicaux Cellvizio Contrat Liquidité Transfert Titres Société MAUNA KEA TECHNOLOGIES
BRIEF published on 11/13/2024 at 12:21, 1 year 5 months ago Mauna Kea Technologies : Bilan des développements récents Financement Mauna Kea Technologies Cellvizio Intolérances Alimentaires CellTolerance
BRIEF published on 11/13/2024 at 12:21, 1 year 5 months ago Mauna Kea Technologies: Review of recent developments Funding Mauna Kea Technologies Cellvizio CellTolerance Food Intolerances
PRESS RELEASE published on 11/13/2024 at 12:16, 1 year 5 months ago Informations privilégiées / Autres communiqués Mauna Kea Technologies fait le point sur ses récents développements dans le domaine des intolérances alimentaires et renforce sa structure financière pour accélérer la commercialisation de son programme innovant CellTolerance Structure Financière Mauna Kea Technologies Intolérances Alimentaires CellTolerance Développements Récents
PRESS RELEASE published on 11/13/2024 at 12:16, 1 year 5 months ago Inside Information / Other news releases Mauna Kea Technologies provides an update on recent developments including the launch of its CellTolerance program for food intolerances and strategic initiatives to strengthen its financial structure and commercialize innovative solutions Financial Structure Update Commercialization Mauna Kea Technologies CellTolerance Program
PRESS RELEASE published on 10/17/2024 at 15:10, 1 year 6 months ago Rapport financier semestriel 2024
BRIEF published on 10/17/2024 at 08:05, 1 year 6 months ago Mauna Kea Technologies Shows Positive Clinical Results for Cellvizio in IBS Clinical Study Mauna Kea Technologies Cellvizio IBS Management Gut Barrier Dysfunction
BRIEF published on 10/17/2024 at 08:05, 1 year 6 months ago Mauna Kea Technologies montre des résultats cliniques positifs pour Cellvizio dans le traitement du syndrome du côlon irritable Étude Clinique Cellvizio Technologies Mauna Kea Prise En Charge Du Syndrome Du Côlon Irritable Dysfonctionnement De La Barrière Intestinale
PRESS RELEASE published on 10/17/2024 at 08:00, 1 year 6 months ago Inside Information / Other news releases Mauna Kea Technologies announces new positive clinical results for Cellvizio in food intolerance at UEG Week 2024, highlighting the value of Confocal Laser Endomicroscopy in managing IBS patients IBS Mauna Kea Technologies Cellvizio Clinical Results Food Intolerance
PRESS RELEASE published on 10/17/2024 at 08:00, 1 year 6 months ago Informations privilégiées / Autres communiqués Mauna Kea Technologies annonce de nouveaux résultats cliniques positifs du Cellvizio dans les intolérances alimentaires lors de l'UEG Week 2024, confirmant la stratégie de croissance avec CellTolerance sur un marché de 6 milliards de dollars/an Mauna Kea Technologies Cellvizio UEG Week 2024 Intolérances Alimentaires CellTolerance
Published on 05/06/2026 at 16:30, 1 hour 43 minutes ago Silver Spruce Resources Inc. Announces Results of Annual and Special Meeting of Shareholders
Published on 05/06/2026 at 15:25, 2 hours 48 minutes ago Electrovaya Announces Date for Q2-2026 Financial Results & Conference Call
Published on 05/06/2026 at 15:15, 2 hours 58 minutes ago Karbon-X Reports Increased Engagement as Canadian Facilities Reassess Compliance Exposure Ahead of Carbon Deadlines
Published on 05/06/2026 at 15:12, 3 hours 1 minute ago Revival Gold Announces Closing of $33 Million Brokered Private Placement
Published on 05/06/2026 at 15:00, 3 hours 13 minutes ago Infield Minerals Announces Option Agreement for the Detroit Gold Property in Utah
Published on 05/06/2026 at 17:45, 28 minutes ago Broadpeak publie son chiffre d’affaires du premier trimestre 2026.
Published on 05/06/2026 at 17:32, 41 minutes ago EQS-Adhoc: UNIQA Insurance Group AG successfully places new EUR 500,000,000 fixed to floating rate subordinated (Tier 2) notes
Published on 05/06/2026 at 18:00, 13 minutes ago Mise à disposition des documents relatifs à l'AG du 4 juin 2026
Published on 05/06/2026 at 18:00, 13 minutes ago Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 13 minutes ago Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026
Published on 05/06/2026 at 18:00, 13 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 30 avril 2026
Published on 05/06/2026 at 17:45, 28 minutes ago Information concerning the total number of voting rights and shares 2026 04 30